C-MET can be activated by its cognate ligandhepatocyte growth factor (HGF) 5,6
investigated the eryptosis rate in healthy RBCs treated with different concentrations of IL-6, IL-1, urea, and p -cresol, comparable to their plasma levels in CKD patients, at different time points, and evaluated the cytotoxic effect on RBCs by an in vitro setting
This is thought to occur because individuals with these mutations are less able to detoxify and excrete certain carcinogens, allowing these harmful substances to accumulate and cause damage to cells
High-dose antioxidant therapy during thrombolysis in patients with acute myocardial infarction
[DOI] [PMC free article] [PubMed] [Google Scholar] 75.Heuts J., Varypataki E.M., van der Maaden K., Romeijn S., Drijfhout J.W., van Scheltinga A.T., Ossendorp F., Jiskoot W